New York State Common Retirement Fund Igm Biosciences, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 6,512 shares of IGMS stock, worth $43,304. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,512
Previous 6,512
-0.0%
Holding current value
$43,304
Previous $45,000
140.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding IGMS
# of Institutions
81Shares Held
20.7MCall Options Held
68KPut Options Held
52.2K-
Baker Bros. Advisors LP New York, NY4.09MShares$27.2 Million0.72% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.01MShares$26.7 Million0.01% of portfolio
-
Siren, L.L.C. New York, NY3.33MShares$22.1 Million2.75% of portfolio
-
Redmile Group, LLC San Francisco, CA3.07MShares$20.4 Million3.32% of portfolio
-
Goldman Sachs Group Inc New York, NY1.26MShares$8.37 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $193M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...